New York, NY – March 25, 2026 — The clock is running. HITLAB’s Breakthrough Alliance (BTA) Europe Conference opens March 31 in Paris — and a limited number of complimentary registrations are still available.

This is not a conference about innovation. It’s a conference that implements it.

Taking place March 31–April 1 at the storied Hôtel-Dieu — one of Europe’s most historic centers of healing — BTA Europe will convene a hand-selected group of healthcare executives, innovators, investors, and policymakers for two days of high-stakes collaboration, strategic alignment, and real-world deal-making.

The room will include senior leaders from Roche, Eli Lilly, Sanofi, Medidata, Procter & Gamble, Novo Nordisk, Merck, and others — alongside health system executives, venture leaders, and government officials actively shaping care delivery across Europe and beyond.

The agenda is built around the decisions that can’t wait:

• Scaling AI and digital health from pilot to clinical practice — now
• Advancing women’s health innovation at the pace the moment demands
• Unlocking market access and regulatory pathways that have stalled progress
• Driving measurable, system-wide outcomes — not incremental wins
• Building the cross-sector partnerships that move ideas off whiteboards and into hospitals

“We created Breakthrough Alliance Europe to bring the right leaders into one room — not to talk about innovation, but to implement it,” said Dr. Stan Kachnowski, Chair, HITLAB. “This is where validated solutions meet real-world adoption.”

BTA Europe is deliberately different. No exhibit hall noise. No passive panels. Instead: private strategic sessions, direct access to decision-makers, and structured pathways to partnership and execution.

Participation is completely complimentary — because HITLAB believes that the people driving change shouldn’t face a paywall to connect.

But space is genuinely limited. If you’re reading this, act now.

Health systems across Europe are under pressure that won’t ease on its own. BTA Europe exists to accelerate what’s already working — and put it in the hands of those who can scale it.

Your seat at the table is waiting.